Catalog Number 810081 |
Device Problem
Material Erosion (1214)
|
Patient Problems
Erosion (1750); Pain (1994); Surgical procedure (2357); Blood Loss (2597); No Code Available (3191)
|
Event Type
Injury
|
Event Description
|
It was reported that the patient underwent a gynecological surgical procedure on (b)(6) 2006 and a sling was implanted.The patient experienced pain, erosion of her internal bodily tissue and other injuries following the procedure.The patient has undergone multiple surgeries and revisionary procedures.No additional information was provided.
|
|
Manufacturer Narrative
|
(b)(4).Conclusion: no conclusion can be drawn at this time.Should additional information be obtained, a supplemental 3500a form will be submitted accordingly.In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.E2013037.Total number of events - 1175.Gynecare tvt - 96.Gynecare tvt abrevo continence system - 67.Gynecare tvt exact continence system - 98.Gynecare tvt obturator system - 493.Gynecare tvt retropubic system -349.Gynecare tvt-aa abdominal - 72.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption (b)(4).Reporting period february 1, 2015 through march 31, 2015.
|
|
Manufacturer Narrative
|
(b)(4).Reporting period (b)(4) 2015.
|
|
Manufacturer Narrative
|
Date sent to the fda: 04/22/2016.(b)(4).Reporting period february 1, 2015 through march 31, 2015, supplemental 06.
|
|
Manufacturer Narrative
|
It was reported that the patient concurrently underwent ligation tubal laparoscopic via filshe clips.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.Reporting period (b)(6) 2015 through (b)(6) 2015.(b)(4).
|
|
Manufacturer Narrative
|
(b)(4).
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Ethicon mdr summary reporting exemption e2013037.
|
|
Manufacturer Narrative
|
Date sent to fda: 2/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2015 through march 31, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 04/23/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2015 through march 31, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 12/20/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2015 through march 31, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 12/27/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2015 through march 31, 2015.
|
|
Manufacturer Narrative
|
Date sent to fda: 06/23/2020.
|
|
Manufacturer Narrative
|
Date sent to fda: 06/18/2021.
|
|
Manufacturer Narrative
|
Date sent to fda: 08/20/2021.Ethicon mdr summary reporting exemption e2013037.Reporting period february 1, 2015 through march 31, 2015.
|
|
Search Alerts/Recalls
|